FDA approves second generic mifepristone, drawing criticism from anti-abortion groups despite the drug's long safety record.
Government shutdown delays key economic data, complicating Fed's decision-making and raising uncertainty for investors and retirees.
FICO's new direct licensing program aims to increase competition and transparency in mortgage lending by cutting out the credit bureaus' intermediary role.
FDA approves second generic mifepristone, drawing criticism from anti-abortion groups despite the drug's long safety record.
Government shutdown delays key economic data, complicating Fed's decision-making and raising uncertainty for investors and retirees.
FICO's new direct licensing program aims to increase competition and transparency in mortgage lending by cutting out the credit bureaus' intermediary role.